banner
Epigenetic reader domain inhibitor BRD-IN-3, Purity ≥98%
Inquiry

Cat. No.: X24-05-ZQ427

Epigenetic reader domain inhibitor BRD-IN-3, Purity ≥98%

Synonym: 2351938-32-2; BRD-IN-3; CHEMBL4574669; 2-{[(3R,5R)-5-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-methylpiperidin-3-yl]amino}-3-methyl-3,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one; BDBM50512964; Epigenetic reader domain inhibitor

  • CAS Number: 2351938-32-2
  • Compound CID: 138105961
img
Product Size
5 mg; 10 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
BRD-IN-3 disrupts the function of proteins that recognize and bind specific epigenetic marks, affecting the interpretation of epigenetic signals.
Molecular Weight
395.45
Molecular Formula
C21H25N5O3
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
BRD-IN-3 can be used to study the inhibition of bromodomain-containing proteins, contributing to the understanding of epigenetic regulation and cancer.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0